Cargando…
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene
Sarcomas are malignant mesenchymal tumors that are extremely rare and divergent. Fusion genes are involved in approximately 30% of sarcomas as driver oncogenes; however, their detailed functions are not fully understood. In this study, we determined the functional significance of 59 sarcoma‐related...
Autores principales: | Hirose, Takeshi, Ikegami, Masachika, Kojima, Shinya, Yoshida, Akihiko, Endo, Makoto, Shimada, Eijiro, Kanahori, Masaya, Oyama, Ryunosuke, Matsumoto, Yoshihiro, Nakashima, Yasuharu, Kawai, Akira, Mano, Hiroyuki, Kohsaka, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551592/ https://www.ncbi.nlm.nih.gov/pubmed/37592448 http://dx.doi.org/10.1111/cas.15915 |
Ejemplares similares
-
COL1A1-PDGFB fusion uterine sarcoma and its response to Imatinib therapy
por: Grindstaff, Samuel L., et al.
Publicado: (2020) -
COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
por: Grindstaff, Samuel L., et al.
Publicado: (2019) -
COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report
por: Chapagain, Udita, et al.
Publicado: (2023) -
First Case of Allochronic Onset of Two Primary Dermatofibrosarcoma Protuberans Lesions Proved by COL1A1-PDGFB Fusion Gene Analysis
por: IKEDA, Ayano, et al.
Publicado: (2022) -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Shimada, Eijiro, et al.
Publicado: (2021)